CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients

L Renders, M Frisman, M Ufer… - Clinical …, 2007 - Wiley Online Library
It is currently not clear whether the concentration‐time curves of the immunosuppressants
differ with respect to the CYP3A5, MDR1, or MRP2 genotype in dose‐adapted stable kidney …
被引用次数：160 相关文章

[引用][C] CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients

L RENDERS, M FRISMAN, I CASCORBI… - Clinical …, 2007 - pascal-francis.inist.fr
CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in
kidney transplant recipients CNRS Inist Pascal-Francis CNRS Pascal and Francis …

CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients.

L Renders, M Frisman, M Ufer, I Mosyagin… - Clinical …, 2006 - europepmc.org
It is currently not clear whether the concentration-time curves of the immunosuppressants
differ with respect to the CYP3A5, MDR1, or MRP2 genotype in dose-adapted stable kidney …

[引用][C] CYP3A5 Genotype Markedly Influences the Pharmacokinetics of Tacrolimus and Sirolimus in Kidney Transplant Recipients

L Renders, M Frisman, M Ufer, I Mosyagin… - Clinical Pharmacology …, 2006 - cir.nii.ac.jp
CYP3A5 Genotype Markedly Influences the Pharmacokinetics of Tacrolimus and Sirolimus
in Kidney Transplant Recipients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients

L Renders, M Frisman, M Ufer… - Clinical …, 2007 - pubmed.ncbi.nlm.nih.gov
It is currently not clear whether the concentration-time curves of the immunosuppressants
differ with respect to the CYP3A5, MDR1, or MRP2 genotype in dose-adapted stable kidney …

CYP3A5 Genotype Markedly Influences the Pharmacokinetics of Tacrolimus and Sirolimus in Kidney Transplant Recipients.

L Renders, M Frisman, M Ufer… - Clinical …, 2007 - search.ebscohost.com
It is currently not clear whether the concentration–time curves of the immunosuppressants
differ with respect to the CYP3A5, MDR1, or MRP2 genotype in dose-adapted stable kidney …

[引用][C] CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients

L RENDERS, M FRISMAN, M UFER… - Clinical …, 2007 - Nature Publishing Group